Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	View
JYSB2400174	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-08-09	view
JYSB2400100	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products	Supplementary Application	2024-05-06	view
JYSB2300196	甘精胰岛素利司那肽注射液（Ⅱ）	insulin glargine;lixisenatide	Injection	Biological Products(3.1)	Supplementary Application	2023-11-11	view